- Toxicity and response evaluation of the interferon inducer poly ICLC administered at low dose in advanced renal carcinoma and relapsed or refractory lymphoma: a report of two clinical trials of the Eastern Cooperative Oncology Group. Giantonio, B.J., Hochster, H., Blum, R., Wiernik, P.H., Hudes, G.R., Kirkwood, J., Trump, D., Oken, M.M. Investigational new drugs. (2001)